A carregar...
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854680/ https://ncbi.nlm.nih.gov/pubmed/24025590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|